Karachaliou, N., Wei, J., Marques, A. D., & Rosell, R. (2013). Front-line erlotinib in unselected patients with advanced NSCLC and poor performance status - the TOPICAL study. Transl Lung Cancer Res.
Stile di citazione ChicagoKarachaliou, Niki, Jia Wei, Ana Daniela Marques, e Rafael Rosell. "Front-line Erlotinib in Unselected Patients With Advanced NSCLC and Poor Performance Status - the TOPICAL Study." Transl Lung Cancer Res 2013.
Citazione MLAKarachaliou, Niki, Jia Wei, Ana Daniela Marques, e Rafael Rosell. "Front-line Erlotinib in Unselected Patients With Advanced NSCLC and Poor Performance Status - the TOPICAL Study." Transl Lung Cancer Res 2013.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.